SELEPARINA

Medicinal product

(Invented) name

SELEPARINA

Active substance (s)

Nadroparino kalcio druska

Strength

5700 anti-Xa TV/0,6 ml

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti į veną, leisti į arteriją, leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

B01AB06, Nadroparin

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2024-04-19

Date of renewal

Documents

2143_SELEPARINA 5700 PL_2024-04-19.docx

2143_SELEPARINA 5700 PZ_2024-04-19.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Užpildytame švirkšte (0,6 ml tirpalo) yra:	0.6 ml
Nadroparino kalcio druska	5700 anti-Xa TV

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
113495	99614	1099614	užpildytas švirkštas	0,6 ml, N2		Receptinis	LT/L/24/2143/001	Netiekiama	-	-	No	-	-
113496	99615	1099615	užpildytas švirkštas	0,6 ml, N6		Receptinis	LT/L/24/2143/002	Netiekiama	-	-	No	-	-	Download
113498	99617	1099617	užpildytas švirkštas	0,6 ml N10		Receptinis	LT/L/24/2143/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-04-19	Registruotas